{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:52:17Z","timestamp":1773276737049,"version":"3.50.1"},"reference-count":25,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context:<\/jats:title><jats:p>Multiple endocrine neoplasia type 2 (MEN2) is usually caused by missense mutations in the proto-oncogene, RET.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>This study aimed to determine the mutation underlying MEN2A in a female patient diagnosed with bilateral pheochromocytoma at age 31 years and with medullary thyroid carcinoma (MTC) 6 years later.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Leukocyte DNA was used for exome and Sanger sequencing. Wild-type (WT) RET and mutants were expressed in HEK293 cells. Activation of MAPK\/ERK and PI3K\/AKT was analyzed by Western blotting and luciferase assay. The effect of RET mutants on cell proliferation was tested in a colony forming assay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Exome sequencing revealed a 6-nucleotide\/2-amino acid in-frame deletion in exon 7 of RET (c.1512_1517delGGAGGG, p.505_506del). In vitro expression showed that phosphorylation of the crucial tyrosine 905 was much stronger in the p.505_506del RET mutant compared with WT RET, indicating ligand-independent autophosphorylation. Furthermore, the p.505_506del RET mutant induced a strong activation of the MAPK\/ERK pathway and the PI3K\/AKT pathway. Consequently, the p.505_506del RET mutant cells increased HEK293 colony formation 4-fold compared with WT RET.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The finding of bilateral pheochromocytoma and MTC in our patient was highly suspicious of a RET mutation. Exome sequencing revealed a 6-base-pair deletion in exon 7 of RET, an exon not yet associated with MEN2. Increased ligand-independent phosphorylation of the p.505_506del RET mutant, increased activation of downstream pathways, and stimulation of cell proliferation demonstrated the pathogenic nature of the mutation. We therefore recommend screening the whole sequence of RET in MTC and pheochromocytoma patients with red flags for a genetic cause.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2015-2948","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T01:24:01Z","timestamp":1452821041000},"page":"1016-1022","source":"Crossref","is-referenced-by-count":13,"title":["A 6-Base Pair in Frame Germline Deletion in Exon 7 Of<i>RET<\/i>Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A"],"prefix":"10.1210","volume":"101","author":[{"given":"S.","family":"Latteyer","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism (S.L., C.K., D.Z., D.F., L.C.M.), 45141 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Klein-Hitpass","sequence":"additional","affiliation":[{"name":"Institute of Cell Biology (Cancer Research) Faculty of Medicine (.K.-H.), 45141 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Khandanpour","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism (S.L., C.K., D.Z., D.F., L.C.M.), 45141 Essen, Germany"},{"name":"Department of Hematology (C.K.), 45141 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zwanziger","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism (S.L., C.K., D.Z., D.F., L.C.M.), 45141 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. D.","family":"Poeppel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine (T.D.P.), 45141 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. W.","family":"Schmid","sequence":"additional","affiliation":[{"name":"Institute of Pathology (K.W.S.), University of Duisburg-Essen, 45141 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"F\u00fchrer","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism (S.L., C.K., D.Z., D.F., L.C.M.), 45141 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. C.","family":"Moeller","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism (S.L., C.K., D.Z., D.F., L.C.M.), 45141 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0357-4192","authenticated-orcid":false,"given":"Dagmar","family":"F\u00fchrer-Sakel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"2021081912111772600_B1","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/cncr.28661","article-title":"RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma","volume":"120","author":"Krampitz","year":"2014","journal-title":"Cancer"},{"key":"2021081912111772600_B2","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"2021081912111772600_B3","doi-asserted-by":"crossref","first-page":"20885","DOI":"10.1074\/jbc.274.30.20885","article-title":"Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells","volume":"274","author":"Trupp","year":"1999","journal-title":"J Biol Chem"},{"key":"2021081912111772600_B4","doi-asserted-by":"crossref","first-page":"23619","DOI":"10.1074\/jbc.271.39.23619","article-title":"Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase","volume":"271","author":"Worby","year":"1996","journal-title":"J Biol Chem"},{"key":"2021081912111772600_B5","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1074\/jbc.275.5.3568","article-title":"Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase\/AKT signaling pathway","volume":"275","author":"Segouffin-Cariou","year":"2000","journal-title":"J Biol Chem"},{"key":"2021081912111772600_B6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbrc.2004.08.095","article-title":"Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells","volume":"323","author":"Maeda","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2021081912111772600_B7","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/MCB.16.5.2151","article-title":"The full oncogenic activity of Ret\/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma","volume":"16","author":"Borrello","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2021081912111772600_B8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2796.2003.01167.x","article-title":"Cell signalling and gene expression mediated by RET tyrosine kinase","volume":"253","author":"Kurokawa","year":"2003","journal-title":"J Intern Med"},{"key":"2021081912111772600_B9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/bbrc.2001.4338","article-title":"Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation","volume":"281","author":"Hayashi","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"2021081912111772600_B10","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.onc.1201778","article-title":"Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): Evidence for a divergence of the ERKs and JNKs pathways induced by Ret","volume":"16","author":"Chiariello","year":"1998","journal-title":"Oncogene"},{"key":"2021081912111772600_B11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2005.05.010","article-title":"RET tyrosine kinase signaling in development and cancer","volume":"16","author":"Arighi","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"2021081912111772600_B12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000346174","article-title":"2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer","volume":"1","author":"Elisei","year":"2013","journal-title":"Eur Thyroid J"},{"key":"2021081912111772600_B13","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2021081912111772600_B14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000185474","article-title":"Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas","volume":"47","author":"Rodien","year":"1997","journal-title":"Horm Res"},{"key":"2021081912111772600_B15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.onc.1201199","article-title":"Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain","volume":"15","author":"Pasini","year":"1997","journal-title":"Oncogene"},{"key":"2021081912111772600_B16","doi-asserted-by":"crossref","first-page":"35808","DOI":"10.1074\/jbc.M104968200","article-title":"Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site","volume":"276","author":"Anders","year":"2001","journal-title":"J Biol Chem"},{"key":"2021081912111772600_B17","first-page":"481","article-title":"Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation","volume":"12","author":"Iwashita","year":"1996","journal-title":"Oncogene"},{"key":"2021081912111772600_B18","first-page":"509","article-title":"Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations","volume":"243","author":"Takahashi","year":"1998","journal-title":"J Intern Med"},{"key":"2021081912111772600_B19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.2009.03757.x","article-title":"A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization","volume":"73","author":"Castellone","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021081912111772600_B20","first-page":"391","article-title":"The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype","volume":"57","author":"Carlomagno","year":"1997","journal-title":"Cancer Res"},{"key":"2021081912111772600_B21","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/sj.onc.1202202","article-title":"Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines","volume":"17","author":"Chappuis-Flament","year":"1998","journal-title":"Oncogene"},{"key":"2021081912111772600_B22","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1038\/sj.onc.1209669","article-title":"Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2","volume":"25","author":"Mise","year":"2006","journal-title":"Oncogene"},{"key":"2021081912111772600_B23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B","volume":"267","author":"Santoro","year":"1995","journal-title":"Science"},{"key":"2021081912111772600_B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12515","article-title":"Guidelines for the management of thyroid cancer","volume":"81","author":"Perros","year":"2014","journal-title":"Clin Endocrinol"},{"key":"2021081912111772600_B25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/3\/1016\/39806333\/jcem_101_3_1016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/3\/1016\/39806333\/jcem_101_3_1016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:12:27Z","timestamp":1748751147000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/3\/1016\/2804849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,1]]},"published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2015-2948","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,3,1]]},"published":{"date-parts":[[2016,3,1]]}}}